Actiphage TB awarded US Patent grant for diagnostic kit

Actiphage TB enters third clinical trial.

Actiphage TB featured in AACC webinar.
Free to view now.

Actiphage – Confidence
to test for active TB

Loading...

Actiphage TB has a unique role in TB testing as it detects the pathogen escaping from the granuloma

TB drug research

Call to action

One quarter of the world’s population is infected with latent tuberculosis (LTBI), also known as inactive tuberculosis. One in ten people with LTBI will progress to active TB disease.

It is essential to develop newer diagnostic tests with significantly increased predictive value for the development of active disease among those who are infected than the currently available tests for LTBI (WHO, 2017).

Our mission

PBD Biotech developers of Actiphage TB.

Our mission is to support the scale-up of latent tuberculosis test-and-treat campaigns with Actiphage to achieve the goals of the WHO End TB strategy. Leveraging Actiphage’s unique role in detecting active TB, PBD Biotech aims to drive innovation in the novel uses for TB screening and drug management.

PBD Biotech developers of Actiphage TB

Meet us at DxPx partnering event in Munich 5th October

Latest

Loading...

5 October 2023

PBD Biotech finalists for 42plus1 pitch event at DxPx EU

September 26, 2023

PBD Biotech is one of the finalists selected to participate in the 42plus1 pitch event at DxPx EU in Munich, Germany on the 5th October 2023. This follows our participation in DxPx US.

5 October 2023

PBD Biotech finalists for 42plus1 pitch event at DxPx EU

September 26, 2023

PBD Biotech is one of the finalists selected to participate in the 42plus1 pitch event at DxPx EU in Munich,...

Maggie Throup MP (credit: Richard Townshend / House of Commons)

Maggie Throup MP, chair of Diagnostics APPG, to meet leading UK diagnostic companies

September 13, 2023

PBD Biotech is one of the companies represented at a parliamentary reception organised by the British In Vitro Diagnostics Association (BIVDA)

Maggie Throup MP, chair of Diagnostics APPG, to meet leading UK diagnostic companies

September 13, 2023

PBD Biotech is one of the companies represented at a parliamentary reception organised by the British In Vitro Diagnostics Association...

Actiphage TB awarded US Patent grant for diagnostic kit

July 25, 2023

PBD Biotech, developers of Actiphage® TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit.

Actiphage TB awarded US Patent grant for diagnostic kit

July 25, 2023

PBD Biotech, developers of Actiphage® TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured...

Leicester Respiratory Biomedical Research Unit

Actiphage TB enters third clinical trial

July 6, 2023

Actiphage TB is to enter its third clinical trial, which is aimed at validating its utility as a tuberculosis diagnostic. The phage-based diagnostic has potential for detecting TB progression.

Actiphage TB enters third clinical trial

July 6, 2023

Actiphage TB is to enter its third clinical trial, which is aimed at validating its utility as a tuberculosis diagnostic....

1 2 3

Pioneer in phage-based diagnostics

Actiphage – Confidence
to test for active TB

Actiphage TB

Laboratory Support